KG-5
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 563657

CAS#: 877874-85-6

Description: KG-5 is an orally available PDGFRß and B-Raf allosteric inhibitor.

Chemical Structure

img
KG-5
CAS# 877874-85-6
Instruction

Theoretical Analysis

MedKoo Cat#: 563657
Name: KG-5
CAS#: 877874-85-6
Chemical Formula: C20H16F3N7OS
Exact Mass: 459.11
Molecular Weight: 459.450
Elemental Analysis: C, 52.28; H, 3.51; F, 12.41; N, 21.34; O, 3.48; S, 6.98

Price and Availability

Size Price Availability Quantity
50mg USD 650 2 Weeks
100mg USD 1050 2 Weeks
200mg USD 1850 2 Weeks
500mg USD 3450 2 Weeks
Bulk inquiry

Synonym: KG-5; KG 5; KG5;

IUPAC/Chemical Name: 2-(Methylthio)-6-[4-[5-[[3-(trifluoromethyl)phenyl]amino]-1H-1,2,4-triazol-3-yl]phenoxy]-4-pyrimidinamine

InChi Key: CMYHZFCJPORPHY-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H16F3N7OS/c1-32-19-26-15(24)10-16(27-19)31-14-7-5-11(6-8-14)17-28-18(30-29-17)25-13-4-2-3-12(9-13)20(21,22)23/h2-10H,1H3,(H2,24,26,27)(H2,25,28,29,30)

SMILES Code: NC1=NC(SC)=NC(OC2=CC=C(C3=NNC(NC4=CC=CC(C(F)(F)F)=C4)=N3)C=C2)=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 459.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Levine DM, Savarimuthu S, Squires A, Nicholson J, Jay M. Technology-assisted weight loss interventions in primary care: a systematic review. J Gen Intern Med. 2015 Jan;30(1):107-17. doi: 10.1007/s11606-014-2987-6. Epub 2014 Aug 19. Review. PubMed PMID: 25134692; PubMed Central PMCID: PMC4284284.

2: Li L, Tian JH, Yang K, Zhang P, Jia WQ. Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection. Cochrane Database Syst Rev. 2014 Jul 26;(7):CD008439. doi: 10.1002/14651858.CD008439.pub3. Review. PubMed PMID: 25063928.

3: Goring S, Hawkins N, Wygant G, Roudaut M, Townsend R, Wood I, Barnett AH. Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis. Diabetes Obes Metab. 2014 May;16(5):433-42. doi: 10.1111/dom.12239. Epub 2013 Dec 16. Review. PubMed PMID: 24237939.

4: John GK, Douglas NM, von Seidlein L, Nosten F, Baird JK, White NJ, Price RN. Primaquine radical cure of Plasmodium vivax: a critical review of the literature. Malar J. 2012 Aug 17;11:280. doi: 10.1186/1475-2875-11-280. Review. PubMed PMID: 22900786; PubMed Central PMCID: PMC3489597.

5: Karbasi A, Karbasi-Afshar R, Ahmadi J, Saburi A. Retroperitoneal fibrosis as a result of signet ring cell gastric cancer: a case-based review. J Gastrointest Cancer. 2013 Mar;44(1):94-7. doi: 10.1007/s12029-012-9422-1. Review. PubMed PMID: 22851371.

6: Li L, Sun T, Yang K, Zhang P, Jia WQ. Monoclonal CCR5 antibody for treatment of people with HIV infection. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008439. doi: 10.1002/14651858.CD008439.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD008439. PubMed PMID: 21154397.

7: Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord. 2011 Feb;9(1):1-12. doi: 10.1089/met.2010.0031. Epub 2010 Oct 25. Review. PubMed PMID: 20973675.

8: Onishi H, Koyama K, Sakata O, Machida Y. Preparation of chitosan/alginate/calcium complex microparticles loaded with lactoferrin and their efficacy on carrageenan-induced edema in rats. Drug Dev Ind Pharm. 2010 Aug;36(8):879-84. doi: 10.3109/03639040903567109. Review. PubMed PMID: 20345284.

9: Chiara O, Bucci L, Sara A, Bassi G, Vesconi S. Quality and quantity of volume replacement in trauma patients. Minerva Anestesiol. 2008 Jun;74(6):303-6. Review. PubMed PMID: 18500203.

10: Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007 Oct;107(10):1755-67. Review. PubMed PMID: 17904936.

11: Amir J. [Primary herpetic gingivostomatitis--clinical aspects and anti-viral treatment]. Harefuah. 2002 Jan;141(1):81-4, 124. Review. Hebrew. PubMed PMID: 11851116.

12: Amir J. Clinical aspects and antiviral therapy in primary herpetic gingivostomatitis. Paediatr Drugs. 2001;3(8):593-7. Review. PubMed PMID: 11577924.

13: Roberts SB, Mayer J. Holiday weight gain: fact or fiction? Nutr Rev. 2000 Dec;58(12):378-9. Review. PubMed PMID: 11206847.

14: Umemura T. Experimental reproduction of itai-itai disease, a chronic cadmium poisoning of humans, in rats and monkeys. Jpn J Vet Res. 2000 May;48(1):15-28. Review. PubMed PMID: 10927882.

15: Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 1994 Dec;28(4):336-48. Review. PubMed PMID: 7729802.

16: Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences]. Infusionsther Transfusionsmed. 1993 Apr;20 Suppl 1:131-5; discussion 136. Review. German. PubMed PMID: 8499742.

17: Gordovilla Zurdo G, Cabo Salvador J, Moreno Granados F, Alvarez Díaz F. [Surgery of symptomatic interauricular communication in the first year of life]. An Esp Pediatr. 1988 Aug;29(2):94-8. Review. Spanish. PubMed PMID: 3056156.

18: Säwe J. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. Review. PubMed PMID: 3514045.

19: Thorngren M, Gustafson A. Effects of acetylsalicylic acid and dietary intervention on primary hemostasis. Am J Med. 1983 Jun 14;74(6A):66-71. Review. PubMed PMID: 6344628.